Javier Limeres Freire

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the <i>TTN</i> Gene

Mohammed Akhtar, Massimiliano Lorenzini, Marcos Cicerchia et al. · Circulation Heart Failure · 2020 · 167 citations · Full text

Medicine, Cardiology, Genetics +15

Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator

Alexandros Protonotarios, Riccardo Bariani, Chiara Cappelletto et al. · European Heart Journal · 2022 · 102 citations · Full text

Medicine, Cardiology, Genetics +17

Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction

Guillem Casas, Javier Limeres Freire, Gerard Oristrell et al. · Journal of the American College of Cardiology · 2021 · 76 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Association of Left Ventricular Systolic Dysfunction Among Carriers of Truncating Variants in Filamin C With Frequent Ventricular Arrhythmia and End-stage Heart Failure

Mohammed Akhtar, Massimiliano Lorenzini, Menelaos Pavlou et al. · JAMA Cardiology · 2021 · 71 citations · Full text

Medicine, Cardiology, Genetics +16